Latest News


CrystecPharma receive patent approval in the  European Union and China - Thumbnail Image

CrystecPharma receive patent approval in the European Union and China

CrystecPharma are pleased to announce the approval of patent applications for their lead asset, CR002. Applications with China’s National Intellectual Property Administration (CNIPA) and the European Patent Office (EPO) have recently been approved. National filings are ongoing in other key territories.

CRYSTECPHARMA AND ICONOVO TO COLLABORATE IN DEVELOPMENT OF INNOVATIVE INHALER PRODUCTS - Thumbnail Image
CrystecPharma win Making Pharmaceuticals Award for Innovation in Manufacturing - Thumbnail Image

CrystecPharma win Making Pharmaceuticals Award for Innovation in Manufacturing

Crystec are honoured to have been awarded the Making Pharmaceuticals Award for Innovation in Manufacturing. The award was presented for Crystec’s mSAS® (modified Supercritical Anti-Solvent) technology and chosen from shortlisted companies including kg-pharma, iDi Pac, Glatt Protech and SSPC, Bernal Institute.

What does 2019 have in store for Pharma? - Thumbnail Image

What does 2019 have in store for Pharma?

Crystec’s CEO, Paul Thorning, has contributed to an article by UBM featuring the big issues affecting Pharma for 2019, according to key opinion leaders in the industry. Contributors include representatives from PharmSource, Catalent Pharma Solutions and NIBRT.